Memphis Pharmaceuticals (MPCI.CA) - Amendments in the Board of Directors
Company Name : Memphis Pharmaceuticals
ISIN Code : EGS38351C010
Reuters Code : MPCI.CA
Content :
Amendments in the Board of Directors
News Attachment (211 KB)
ISIN Code : EGS38351C010
Reuters Code : MPCI.CA
Content :
Amendments in the Board of Directors
News Attachment (211 KB)
Comments